Cargando…

Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials

BACKGROUND: The survival benefit of neoadjuvant therapy in resectable carcinoma esophagus has been elucidated. We performed a meta-analysis in light of new studies and long-term results of past trials. The search strategy was refined to include only “neoadjuvant” so that any bias by adjuvant treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Tarun, Pai, Esha, Singh, Rajesh, Francis, Neville J., Pandey, Manoj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085863/ https://www.ncbi.nlm.nih.gov/pubmed/32199464 http://dx.doi.org/10.1186/s12957-020-01830-x

Ejemplares similares

Lymphadenectomy in ovarian cancers: a meta-analysis of hazard ratios from randomized clinical trials
por: Purwar, Roli, et al.
Publicado: (2022)

A network meta-analysis for neoadjuvant and adjuvant treatments for resectable squamous cell carcinoma of esophagus
por: Zhao, Yunpeng, et al.
Publicado: (2021)

Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction
por: Kamarajah, S. K., et al.
Publicado: (2020)

Systemic treatments for resectable carcinoma of the esophagus
por: Leowattana, Wattana, et al.
Publicado: (2023)

Sternocleidomastoid flap for pedicled reconstruction in head & neck surgery- revisiting the anatomy and technique
por: Srivastava, Apurva, et al.
Publicado: (2021)

Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus
por: Heise, Joachim W, et al.
Publicado: (2001)

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials
por: Zhao, Xin, et al.
Publicado: (2018)

Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus
por: Münch, Stefan, et al.
Publicado: (2019)

Comment on “Oncological Outcomes After Anastomotic Leakage After Surgery for Colon or Rectal Cancer: Increased Risk of Local Recurrence”
por: Pai, Esha, et al.
Publicado: (2022)

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Cloyd, Jordan M., et al.
Publicado: (2020)

Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta‐analysis
por: Fan, Mengying, et al.
Publicado: (2015)

Factors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction
por: Nusrath, Syed, et al.
Publicado: (2022)

Neoadjuvant Treatment Strategies in Resectable Pancreatic Cancer
por: Lambert, Aurélien, et al.
Publicado: (2021)

Functional Polymorphisms Associated with Disease-Free Survival in Resected Carcinoma of the Esophagus
por: Boonstra, Jurjen J., et al.
Publicado: (2010)

Prognostic value of neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomized controlled trials
por: Liu, Shangtong, et al.
Publicado: (2023)

Assessing failure patterns of radical intent radiation strategies in patients with locally advanced carcinoma of the esophagus
por: Mishra, Shagun, et al.
Publicado: (2020)

MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
por: Slotta-Huspenina, Julia, et al.
Publicado: (2018)

VERRUCOUS CARCINOMA OF THE ESOPHAGUS INVOLVING THE ENTIRE ESOPHAGUS
por: BRANDALISE, André, et al.
Publicado: (2015)

Huge Lymphangioma of the Esophagus Resected by Endoscopic Piecemeal Mucosal Resection
por: Luo, Dinghai, et al.
Publicado: (2017)

Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
por: Crook, Christiana J., et al.
Publicado: (2023)

Definitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable disease
por: Ishikura, Satoshi, et al.
Publicado: (2020)

Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials
por: Fu, Tao, et al.
Publicado: (2015)

Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus
por: Münch, Stefan, et al.
Publicado: (2017)

Correction to: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
por: Slotta-Huspenina, Julia, et al.
Publicado: (2018)

Neoadjuvant chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: Meta-analysis and trial sequential analysis of randomized controlled trials
por: Hajibandeh, Shahab, et al.
Publicado: (2023)

Verrucous Carcinoma of the Esophagus
por: Ogawa, Ryo, et al.
Publicado: (2016)

Polypoid Carcinoma of the Esophagus
por: Mori, Masaki, et al.
Publicado: (1994)

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)
por: van Heijl, M, et al.
Publicado: (2008)

Rad51 Expression Is a Useful Predictive Factor for the Efficacy of Neoadjuvant Chemoradiotherapy in Squamous Cell Carcinoma of the Esophagus
por: Nakanoko, Tomonori, et al.
Publicado: (2013)

Effectiveness of neoadjuvant chemotherapy with cisplatin and irinotecan followed by surgery on small-cell carcinoma of the esophagus: A case report
por: Akiyama, Yuji, et al.
Publicado: (2015)

Role of PARP inhibitors beyond BRCA mutation and platinum sensitivity in epithelial ovarian cancer: a meta-analysis of hazard ratios from randomized clinical trials
por: Purwar, Roli, et al.
Publicado: (2023)

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma
por: Domenge, C, et al.
Publicado: (2000)

Neoadjuvant Immune Checkpoint Inhibitors for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Zhao, Mei, et al.
Publicado: (2023)

A thoracoscopically resected case of the diverticulum in the middle esophagus
por: Yatabe, Kentaro, et al.
Publicado: (2019)

Neoadjuvant treatment strategies for hepatocellular carcinoma
por: Xu, Lei, et al.
Publicado: (2021)

A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
por: Anvari, Kazem, et al.
Publicado: (2015)

Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
por: Iyengar, Siddharth, et al.
Publicado: (2021)

Safety of Neoadjuvant Immunotherapy in Resectable Cancers: A Meta-Analysis
por: Xu, Jiawei, et al.
Publicado: (2022)

Neoadjuvant chemoradiotherapy for resectable gastric cancer: A meta-analysis
por: Chen, Jiuzhou, et al.
Publicado: (2022)

Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
por: Li, Xiangji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aa7f0ajra6lfkhig4q0de83vas